Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of solid tumor drugs sourced from Novo Nordisk and Prelude Therapeutics. The ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...

Why you can trust What Hi-Fi? Our expert team reviews products in dedicated test rooms, to help you make the best choice for your budget. Find out more about how we test. Few companies combine style ...

The Pathos Ethos mixes style with substance better than any rival we can think of Best stereo amplifiers 2026: 8 class leaders chosen by our review experts Best hi-fi systems 2026: CD, vinyl and ...